Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 292.50
-32.00 (-9.86%)
Feb 11, 2026, 1:30 PM CST
Lotus Pharmaceutical Revenue
Lotus Pharmaceutical had revenue of 4.77B TWD in the quarter ending September 30, 2025, a decrease of -8.86%. This brings the company's revenue in the last twelve months to 18.66B, up 6.04% year-over-year. In the year 2024, Lotus Pharmaceutical had annual revenue of 18.58B with 9.59% growth.
Revenue (ttm)
18.66B
Revenue Growth
+6.04%
P/S Ratio
4.12
Revenue / Employee
16.98M
Employees
1,099
Market Cap
76.92B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 18.58B | 1.63B | 9.59% |
| Dec 31, 2023 | 16.96B | 2.33B | 15.89% |
| Dec 31, 2022 | 14.63B | 1.98B | 15.68% |
| Dec 31, 2021 | 12.65B | 1.92B | 17.90% |
| Dec 31, 2020 | 10.73B | 1.12B | 11.63% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals | 21.10B |
| PharmaEssentia | 13.82B |
| Grape King Bio | 10.40B |
| YungShin Global Holding | 8.37B |
| TTY Biopharm Company | 6.50B |
| Synmosa Biopharma | 6.11B |
| ScinoPharm Taiwan | 3.19B |
| Handa Pharmaceuticals | 1.62B |